Open House Original Discount Agreements 2025-25 - Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamid (active ingredient combination)
Open House Originale Rabattverträge 2025-25 - Darunavir/Cobicistat/Emtricitabin/Tenofovir alafenamid (Wirkstoffkombination)
Germany
Contract
BuyerTechniker Krankenkasse
TypeSupplies
Estimated valuevalue not published
Published22 August 2025
CategoryMedical equipment & pharma · CPV 33000000
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Computacenter AG & Co. oHG | 76 | 2006–2026 |
| Siehe im Feld "Allgemeine Informationen" | 55 | 2023–2026 |
| Hexal AG · Holzkirchen | 43 | 2011–2026 |
| Aliud Pharma GmbH · Laichingen | 38 | 2011–2025 |
| Aristo Pharma GmbH · Berlin | 33 | 2012–2026 |
From 13.7M documented awards · regular winners know this buyer's requirements — that is your competition.
How often this buyer tenders this
201986
202036
202122
202229
202354
2024263
20251
2025550
2026275
Who knows the rhythm prepares instead of reacting.
438
days until the deadline — Sunday 31 October at 21:58
How to bid
Read the full notice — Original + documents
Goes directly to this tender on Vergabemarktplatz (cosinex). The full specification and all annexes are there.
Tenders like this, every morning at 7:30 in your inbox.
Start free →